Effect of rhTACI-Ig fusion protein on antigen-specific T cell responses from keyhole limpet haemocyanin challenged mice

Molecular Immunology

Volumn 49, Issue 1-2, 2011, Pages 380-386

  Wang, Qing Tong ^a   Ma, Yu Kun ^a   Huang, Bei ^a   Liu, Dan Dan ^a   Wei, Wei ^a  

^a ANHUI MEDICAL UNIVERSITY   (China)

Author keywords

B cell activating factor belonged to TNF family (BAFF); Immunological regulation; Immunotherapy; Keyhole limpet haemocyanin (KLH); T cells; Transmembrane activator and calcium modulator and cyclophilin ligand interactor (TACI)

Indexed keywords

APRIL PROTEIN; B CELL ACTIVATING FACTOR; FC RECEPTOR; GAMMA INTERFERON; HYBRID PROTEIN; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M ANTIBODY; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 5; KEYHOLE LIMPET HEMOCYANIN; RECOMBINANT TRANSMEMBRANE ACTIVATOR AND CAML INTERACTOR; TRANSMEMBRANE ACTIVATOR AND CAML INTERACTOR; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIGEN SPECIFICITY; ARTICLE; B LYMPHOCYTE; CELL HYPERPLASIA; CELL STIMULATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DOWN REGULATION; HISTOPATHOLOGY; IMMUNOMODULATION; IMMUNOREGULATION; LIGAND BINDING; LYMPH FOLLICLE; LYMPHOCYTE PROLIFERATION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SPLEEN; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION;

ANIMALS; B-CELL ACTIVATING FACTOR; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL SEPARATION; FLOW CYTOMETRY; HEMOCYANIN; HUMANS; LYMPHOCYTE ACTIVATION; MALE; MICE; MICE, INBRED C57BL; RECOMBINANT FUSION PROTEINS; SPLEEN; T-LYMPHOCYTES; TUMOR NECROSIS FACTOR LIGAND SUPERFAMILY MEMBER 13;

MUS;

EID: 82455192382     PISSN: 01615890     EISSN: 18729142     Source Type: Journal    
DOI: 10.1016/j.molimm.2011.09.007     Document Type: Article

References (27)

1. Batten M., Groom J., Cachero T.G., Qian F., Schneider P., Tschopp J., Browning J.L., Mackay F. BAFF mediates survival of peripheral immature B lymphocytes. The Journal of Experimental Medicine 2000, 192:1453.
2. Bosello S., Youinou P., Daridon C., Tolusso B., Bendaoud B., Pietrapertosa D., Morelli A., Ferraccioli G. Concentrations of BAFF correlate with autoantibody levels, clinical disease activity, and response to treatment in early rheumatoid arthritis. The Journal of Rheumatology 2008, 35:1256.
3. Chang Y., Wu Y., Wang D., Wei W., Qin Q., Xie G., Zhang L., Yan S., Chen J., Wang Q. Therapeutic effects of TACI-Ig on rats with adjuvant-induced arthritis via attenuating inflammatory responses. Rheumatology 2011, 50:862.
4. Dillon S.R., Harder B., Lewis K.B., Moore M.D., Liu H., Bukowski T.R., Hamacher N.B., Lantry M.M., Maurer M., Krejsa C.M. B-lymphocyte stimulator/a proliferation-inducing ligand heterotrimers are elevated in the sera of patients with autoimmune disease and are neutralized by atacicept and B-cell maturation antigen-immunoglobulin. Arthritis Research and Therapy 2010, 12:111.
5. Hsieh C.S., Macatonia S.E., O'Garra A., Murphy K.M. T cell genetic background determines default T helper phenotype development in vitro. The Journal of Experimental Medicine 1995, 181:713.
6. Jiang C., Loo W.M., Greenley E.J., Tung K.S., Erickson L.D. B cell maturation antigen deficiency exacerbates lymphoproliferation and autoimmunity in murine lupus. Journal of Immunology 2011, 186:6136-6147.
7. John Looney R., Anolik J., Sanz I. A perspective on B-cell-targeting therapy for SLE. Modern Rheumatology 2010, 20:1-10.
8. Lee J., Sadelain M., Brentjens R. Retroviral transduction of murine primary T lymphocytes. Methods in Molecular Biology 2009, 506:83-96.
9. Mandik-Nayak L., Ridge N., Fields M., Park A.Y., Erikson J. Role of B cells in systemic lupus erythematosus and rheumatoid arthritis. Current Opinion in Immunology 2008, 20:639-645.
10. Marston B., Looney R.J. Connective tissue diseases: translating the effects of BAFF in SLE. Nature Reviews Rheumatology 2010, 6:503-504.
11. Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. Journal of Immunological Methods 1983, 65:55-63.
12. Plitnick L.M., Herzyk D.J. The T-dependent antibody response to keyhole limpet hemocyanin in rodents. Methods in Molecular Biology 2010, 598:159-171.
13. Ramanujam M., Bethunaickan R., Huang W., Tao H., Madaio M.P., Davidson A. Selective blockade of BAFF for the prevention and treatment of systemic lupus erythematosus nephritis in NZM2410 mice. Arthritis & Rheumatism 2010, 62:1457-1468.
14. Raza K., Falciani F., Curnow S.J., Ross E.J., Lee C.Y., Akbar A.N., Lord J.M., Gordon C., Buckley C.D., Salmon M. Early rheumatoid arthritis is characterized by a distinct and transient synovial fluid cytokine profile of T cell and stromal cell origin. Arthritis Research and Therapy 2005, 7:784-795.
15. Schiemann B., Gommerman J.L., Vora K., Cachero T.G., Shulga-Morskaya S., Dobles M., Frew E., Scott M.L. An essential role for BAFF in the normal development of B cells through a BCMA-independent pathway. Science 2001, 293:2111.
16. Schneider P., MacKay F., Steiner V., Hofmann K., Bodmer J.L., Holler N., Ambrose C., Lawton P., Bixler S., Acha-Orbea H., Valmori D., Romero P., Werner-Favre C., Zubler R.H., Browning J.L., Tschopp J. BAFF, a novel ligand of the tumor necrosis factor family, stimulates B cell growth. The Journal of Experimental Medicine 1999, 189:1747-1756.
17. Seyler T.M., Park Y.W., Takemura S., Bram R.J., Kurtin P.J., Goronzy J.J., Weyand C.M. BLyS and APRIL in rheumatoid arthritis. The Journal of Clinical Investigation 2005, 115:3083-3092.
18. Tak P.P., Thurlings R.M., Rossier C., Nestorov I., Dimic A., Mircetic V., Rischmueller M., Nasonov E., Shmidt E., Emery P., Munafo A. Atacicept in patients with rheumatoid arthritis: results of a multicenter, phase Ib, double-blind, placebo-controlled, dose-escalating, single- and repeated-dose study. Arthritis & Rheumatism 2008, 58:61-72.
19. Tan S.M., Xu D., Roschke V., Perry J.W., Arkfeld D.G., Ehresmann G.R., Migone T.S., Hilbert D.M., Stohl W. Local production of B lymphocyte stimulator protein and APRIL in arthritic joints of patients with inflammatory arthritis. Arthritis & Rheumatism 2003, 48:982-992.
20. Townsend M.J., Monroe J.G., Chan A.C. B-cell targeted therapies in human autoimmune diseases: an updated perspective. Immunological Reviews 2010, 237:264-283.
21. Van Panhuys N., Tang S.C., Prout M., Camberis M., Scarlett D., Roberts J., Hu-Li J., Paul W.E., Le Gros G. In vivo studies fail to reveal a role for IL-4 or STAT6 signaling in Th2 lymphocyte differentiation. Proceedings of the National Academy of Sciences of the United States of America 2008, 105:12423.
22. Varfolomeev E., Kischkel F., Martin F., Seshasayee D., Wang H., Lawrence D., Olsson C., Tom L., Erickson S., French D. APRIL-deficient mice have normal immune system development. Molecular and Cellular Biology 2004, 24:997.
23. Varin M.M., Le Pottier L., Youinou P., Saulep D., Mackay F., Pers J.O. B-cell tolerance breakdown in Sjögren's syndrome: focus on BAFF. Autoimmunity Reviews 2010, 9:604-608.
24. Wang D., Chang Y., Wu Y., Zhang L., Yan S., Xie G., Qin Q., Jin J., Wang W., Fang J., Wei W. Therapeutic effects of TACI-Ig on rat with adjuvant arthritis. Clinical & Experimental Immunology 2010, 163:225-234.
25. Woo Y.J., Yoon B.Y., Jhun J.Y., Oh H.J., Min S., Cho M.L., Park S.H., Kim H.Y., Min J.K. Regulation of B cell activating factor (BAFF) receptor expression by NF-κB signaling in rheumatoid arthritis B cells. Experimental and Molecular Medicine 2011, 43:350-357.
26. Woodland R.T., Fox C.J., Schmidt M.R., Hammerman P.S., Opferman J.T., Korsmeyer S.J., Hilbert D.M., Thompson C.B. Multiple signaling pathways promote B lymphocyte stimulator-dependent B-cell growth and survival. Blood 2008, 111:750.
27. Yang J., Pospisil R., Ray S., Milton J., Mage R.G. Investigations of a rabbit (Oryctolagus cuniculus) model of systemic lupus erythematosus (SLE). BAFF and its receptors. PLoS One 2009, 4:e8494.